Heghine Khachatryan: What EHA 2026 Reveals About the Future of Aplastic Anemia Treatment
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared American Society of Hematology’s post on LinkedIn:
“Aplastic Anemia in 2026: Moving Beyond Traditional IST
The management of severe aplastic anemia continues to evolve.
While horse ATG plus cyclosporine remains the backbone of frontline immunosuppressive therapy, recent studies and EHA 2026 discussions highlight the growing role of thrombopoietin receptor agonists (especially eltrombopag) in improving hematologic responses and reducing transfusion dependence.
Key trends shaping 2026 practice include:
- Earlier integration of TPO-receptor agonists into frontline therapy
- Improved risk stratification through molecular profiling and clonal evolution monitoring
- More individualized treatment selection based on age, donor availability, and genomic findings
- Ongoing refinement of the balance between immunosuppression and stem cell transplantation strategies
The future of aplastic anemia treatment is increasingly focused on precision medicine, deeper responses, and long-term prevention of clonal progression.”
American Society of Hematology shared a post on LinkedIn:
“How is frontline immunosuppressive therapy for aplastic anemia evolving in 2026?
Join the next Aplastic Anemia Clinical Case Webinar focusing on highlights from EHA 2026 and practical, evidence-based strategies for patient management.
June 18 | 6–7 p.m.
Register now.”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Jun 13, 2026, 12:50Cornelia Englisch: Insights Into Clonal Hematopoiesis and Thrombosis Risk at EHA 2026
-
Jun 13, 2026, 11:18Mavis Agnes Kisakye: Transforming Lives Through the WFH Humanitarian Aid Program in Uganda
-
Jun 13, 2026, 10:48Humberto Cruz Esparra: Stroke Recovery Is More Than Regaining Function
-
Jun 13, 2026, 10:43Karina Sultankulova: Smarter D-Dimer Strategies for Safe and Efficient DVT Exclusion
-
Jun 13, 2026, 10:34Kelvin Hill: The Updated Stroke Clinical Care Standard Is Out Now
-
Jun 13, 2026, 10:04Johanna Gebhart: New Publication from the Vienna Bleeding Biobank Advancing BDUC Research Is Now Live
-
Jun 13, 2026, 08:50Alfadil Haroon: Decoding the Complexity of Factor II Deficiency at EHA 2026
-
Jun 13, 2026, 08:44Omid Seidizadeh: Honored to Present on Advances in VWD Management at EHA 2026
-
Jun 13, 2026, 02:23Ruben Mesa: Honoring MPN Legend Prof. Claire Harrison